Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients

INTRODUCTION: Currently, no effective therapies exist to reduce the high mortality associated with dialysis-dependent acute kidney injury (AKI-D). Serum biomarkers may be useful in understanding the pathophysiological processes involved with AKI and the severity of injury, and point to novel therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Li-Rong, Sun, Jinchun, Daniels, Jaclyn R., Cao, Zhijun, Schnackenberg, Laura, Choudhury, Devasmita, Palevsky, Paul M., Ma, Jennie Z., Beger, Richard D., Portilla, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127416/
https://www.ncbi.nlm.nih.gov/pubmed/30197987
http://dx.doi.org/10.1016/j.ekir.2018.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127416/
https://www.ncbi.nlm.nih.gov/pubmed/30197987
http://dx.doi.org/10.1016/j.ekir.2018.04.012

Ejemplares similares